Abilify Maintena is an extended-release injectable suspension designed for the treatment of schizophrenia and bipolar I disorder. This once-monthly injection provides a consistent delivery of aripiprazole, helping to stabilize symptoms effectively.
Key FeaturesIdeal for patients requiring long-term management of schizophrenia or bipolar I disorder.
Typical User/Industry ProfileHealthcare professionals administering treatment for mental health disorders.
About the BrandAbilify Maintena is a trusted name in the field of mental health treatment, known for its innovative approach to long-term symptom management.